The U.S. banking market is beginning to turn a corner, with large institutions preparing to redeploy significant capital into lending after an extended period of constraint. For much of the past two years, banks operated defensively as rising rates, balance sheet pressure, and evolving capital requirements limited their ability to underwrite and hold risk. That dynamic is now shifting. Regulators, including the Federal Reserve, the Federal Deposit Insurance Corporation and the Office of the Comptroller of the Currency, have signaled a more measured path for capital rule implementation, effectively easing near-term pressure on bank balance sheets and allowing institutions to re-engage more actively in credit markets.
The practical implication is straightforward: banks have capacity again and they are incentivized to use it. Over the past 18 months, many lenders have reduced underwriting commitments, pulled back hold sizes and lost market share to private credit providers that have stepped in to fill the void. Today, that dynamic is beginning to reverse. With improved visibility on capital treatment and ample liquidity on balance sheets, banks are re-entering the market with greater willingness to lend, particularly where risk-adjusted returns are most attractive.
This shift is most visible in leveraged finance and corporate lending. Sponsor-backed transactions are seeing improved bank participation, with more competitive pricing and a greater willingness to underwrite larger commitments. At the same time, investment-grade and upper middle market borrowers are benefiting from tighter spreads and increased lender competition. While commercial real estate remains more constrained, even that market may see incremental liquidity for high-quality assets as refinancing needs accelerate.
For M&A, the implications are meaningful and immediate. Financing availability is one of the primary gating factors for deal activity and its absence has been a key reason for muted volumes. As banks return, deal certainty improves, enabling buyers to transact with greater confidence and speed. More importantly, the cost and structure of capital begin to normalize, which supports valuation stability for high-quality assets. In practice, this means competitive processes are more likely to clear, sponsor-backed deals become more executable and strategic buyers face renewed competition from financial sponsors.
That said, this is not a broad-based reopening of credit. Banks remain selective and are prioritizing scale, cash flow visibility and sector resilience. As a result, the initial benefits of this shift are accruing disproportionately to larger, higher-quality businesses, while the middle market continues to recover more gradually. This bifurcation is critical: while capital is returning, it is not returning evenly.
The re-emergence of banks also introduces a more competitive dynamic with private credit, which expanded rapidly during the period of bank retrenchment. Borrowers should benefit from improved terms and greater optionality, though private lenders will continue to play a key role in more complex or higher-risk situations where banks remain cautious.
The bottom line is that a key overhang on the market, bank balance sheet constraint, is beginning to lift. As capital is redeployed, lending conditions are improving, financing markets are reopening and the foundation for a more active M&A environment is being re-established. The recovery may be uneven, but directionally, the market is moving toward a more functional and competitive deal landscape.
M&A Market Activity
U.S. deal volume grew by 15.2 percent in the first quarter of 2026 compared with the same period last year, indicating continued stabilization, with deal flow supported by improving financing markets and steady corporate demand, though activity remained uneven across segments. Large-cap transactions, particularly in technology, industrials and energy, continued to drive total volume, reflecting strategic buyers’ focus on scale and capability acquisition, while private equity remained more selective as higher borrowing costs constrained leverage. Middle-market activity persisted at a measured pace, with buyers prioritizing earnings visibility and downside protection, reinforcing a disciplined underwriting environment despite gradually improving market confidence.
The Columbus M&A market experienced a 13 percent decline in activity in the first quarter of 2026 compared to the same period in 2025, with several noteworthy transactions completed by both strategic acquirers and private equity firms. Quantum Health, W.W. Williams, and TruArc Partners all completed strategic acquisitions.
Deal of the Month
On March 3, 2026, Dublin-based Quantum Health announced its acquisition of CirrusMD, a premier on-demand virtual care company. The acquisition brings together navigation and physician-led virtual care to drive more immediate care integration and stronger outcomes for members across their health care journey.
This acquisition builds on Quantum Health’s recent momentum expanding clinically-validated provider steerage through Embold Health and launching its expanded solution suite built on a new agentic AI platform further strengthening the company’s ability to act earlier, guide members more effectively and deliver measurable savings.
“Health care needs to work earlier, faster and cost less,” said Dayne Williams, Chief Executive Officer of Quantum Health. “By bringing CirrusMD’s physician-led virtual care directly into our navigation model, we are fundamentally strengthening Real-Time Intercept by engaging members sooner, improving outcomes and delivering meaningful health care cost containment for the employers and members we serve.”
Sources: PitchBook™, S&P Capital IQ, FRED, Federal Reserve, MelCap Investment Banking knowledge, company websites, and public company filings.
Eric W. Mills is an Associate at MelCap Partners LLC, a middle-market investment banking advisory firm. For more information on MelCap Partners, please visit www.melcap.com or email [email protected].